Cargando…

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology

INTRODUCTION: Adults with Down syndrome (DS) are at exceptionally high risk for Alzheimer's disease (AD), with virtually all individuals developing key neuropathological features by age 40. Identifying biomarkers of AD progression in DS can provide valuable insights into pathogenesis and sugges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handen, Benjamin L., Lott, Ira T., Christian, Bradley T., Schupf, Nicole, OBryant, Sid, Mapstone, Mark, Fagan, Anne M., Lee, Joseph H., Tudorascu, Dana, Wang, Mei‐Cheng, Head, Elizabeth, Klunk, William, Ances, Beau, Lai, Florence, Zaman, Shahid, Krinsky‐McHale, Sharon, Brickman, Adam M., Rosas, H. Diana, Cohen, Annie, Andrews, Howard, Hartley, Sigan, Silverman, Wayne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396809/ https://www.ncbi.nlm.nih.gov/pubmed/32775597 http://dx.doi.org/10.1002/dad2.12065

Ejemplares similares

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome
por: Hartley, Sigan L., et al.
Publicado: (2023)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: O'Bryant, Sid E., et al.
Publicado: (2020)

White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study
por: Bazydlo, Austin, et al.
Publicado: (2021)

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: Petersen, Melissa, et al.
Publicado: (2020)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

Language skills as a predictor of cognitive decline in adults with Down syndrome
por: Pulsifer, Margaret B., et al.
Publicado: (2020)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Joint‐label fusion brain atlases for dementia research in Down syndrome
por: Queder, Nazek, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models. Brain Sci. 2021, 11, 1220
por: Hom, Christy L., et al.
Publicado: (2022)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

White matter microstructure associations to amyloid burden in adults with Down syndrome
por: Bazydlo, Austin M., et al.
Publicado: (2021)

Down syndrome: Distribution of brain amyloid in mild cognitive impairment
por: Keator, David B., et al.
Publicado: (2020)

Acute Regression in Down Syndrome
por: Handen, Benjamin, et al.
Publicado: (2021)

Alzheimer's risk and quality of life: History of Down syndrome as a case in point
por: Silverman, Wayne, et al.
Publicado: (2021)

An improved method for detecting telomere size differences in T-lymphocyte interphases from older people with Down syndrome with and without mild cognitive impairment
por: Jenkins, E. C., et al.
Publicado: (2017)

Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome
por: Krinsky‐McHale, Sharon J, et al.
Publicado: (2020)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
por: Tudorascu, DL, et al.
Publicado: (2020)

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen
por: Zammit, Matthew D., et al.
Publicado: (2021)

Individualized estimated years from onset of Alzheimer's disease– related decline for adults with Down syndrome
por: Silverman, Wayne, et al.
Publicado: (2023)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

The Association between Sex and Risk of Alzheimer’s Disease in Adults with Down Syndrome
por: Mhatre, Pooja Girish, et al.
Publicado: (2021)

Altered connectivity of the default mode network in cognitively stable adults with Down syndrome: “Accelerated aging” or a prelude to Alzheimer's disease?
por: Rosas, H. Diana, et al.
Publicado: (2021)

Pathways linking pulse pressure to dementia in adults with Down syndrome
por: Rizvi, Batool, et al.
Publicado: (2023)

Ophthalmic Disorders in Adults with Down Syndrome
por: Krinsky-McHale, Sharon J., et al.
Publicado: (2012)

Physical activity, memory function, and hippocampal volume in adults with Down syndrome
por: Peven, Jamie C., et al.
Publicado: (2022)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review
por: Hamburg, Sarah, et al.
Publicado: (2019)

Aging and Down Syndrome
por: Head, Elizabeth, et al.
Publicado: (2012)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Sleep and White Matter in Adults with Down Syndrome
por: Fleming, Victoria, et al.
Publicado: (2021)

Postmortem Neocortical (3)H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease
por: Pivtoraiko, Violetta N., et al.
Publicado: (2021)

Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease
por: O'Bryant, Sid E.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_adbi4sss13aavdp9j6vb7o2mjl